The Allstate Corporation logo ALL - The Allstate Corporation

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
1
BUY 19
HOLD 23
SELL 1
STRONG
SELL
0
| PRICE TARGET: $250.50 DETAILS
HIGH: $300.00
LOW: $213.00
MEDIAN: $241.00
CONSENSUS: $250.50
DOWNSIDE: 0.44%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 26.2% below fair value
Current Price $251.61
Bear Case $289.85 15.2% upside ($289.85 - $251.61) / $251.61 = 15.2% ROTCE 20.0% → 4.00x TBV
Fair Value $340.80 35.4% upside ($340.80 - $251.61) / $251.61 = 35.4% ROTCE 25.0% → 4.00x TBV
Bull Case $443.04 76.1% upside ($443.04 - $251.61) / $251.61 = 76.1% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

49.5%
6.0%

Key Value Driver

ROTCE (49.5%) vs. cost of equity (6.0%)

Implied Market Multiple 3.12x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $250.50 from 44 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $340.80 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $250.50 (from 44 analysts). Our estimate is 51% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly